Bovine spongiform encephalopathy (BSE, also known as mad cow disease)
has surfaced in Great Britain, France, Switzerland, Canada, Spain,
Germany, Japan, Russia, and, as of December 22, 2003, in the United
States as well. Health authorities consider it to be the most likely
cause of a new variant of Creutzfeldt-Jakob disease (vCJD), a fatal
brain disease that, as of May 2003, has affected 139 people worldwide.1
Americans are now being alerted to the fact that BSE
presents a health threat in the United States. Here, we present
scientific evidence that supports growing concern about BSE and
vCJD and the need for corrective action to protect the health of
humans and animals in the United States:
- The conditions that led to the emergence of BSE in Britain have
also been present in the United States. Although some changes
have been made, many U.S. livestock rendering and feeding practices
are similar to those present in Britain at the onset of the BSE
epidemic.
- The agent that causes BSE has already spread to at least one
cow and some other species of animals in the United States. The
extent to which BSE and other encephalopathies have entered the
human food supply is unknown.
- Between 1979 and 1998, 4,751 Americans died of Creutzfeldt-Jakob
disease, and the possibility that BSE played a role in some of
those deaths cannot be ruled out.2
Brain Disease in Cows
Bovine spongiform encephalopathy is
a fatal central nervous system disease first identified in the UK
in 1986. Affected cows show increased apprehension, poor coordination,
difficulties in walking, and weight loss. The infections that cause
BSE apparently existed for several years before the disease was
recognized in England.3-5
BSE is not limited to Britain. It
has been found in native cattle in France, Switzerland, Northern
Ireland, the Republic of Ireland, the Channel Isles, and the Isle
of Man. Cattle exports carried the disease to Canada, Denmark, Oman,
and the Falkland Islands.3, 6 And the
first case in the United States was reported in December 2003. Moreover,
at least 100,000 cattle whose BSE status is unknown have been shipped
from the UK to other countries. Most of these animals are unaccounted
for.
Related Brain Disease in Humans
vCJD, like other transmissible
encephalopathies, robs an affected individual of mental faculties
and muscle coordination, eventually leading to coma and death. This
category of illnesses is caused by prions, proteins that are normal
in their molecular makeup but abnormal in their shape, like springs
that have been bent out of configuration. It is believed that vCJD
results from contact with prions in tissues of cattle with bovine
spongiform encephalopathy (BSE), or “mad cow disease,”
which, in turn, distort normal proteins in human brain and nerve
cells. Only minuscule amounts of prion-tainted tissues are required
in order to transmit the disease.7 Prions
concentrate in the brain and spinal cord, but also have been found
in blood and muscle tissue. Prions are very difficult to destroy,
even by the chemical or heat disinfectant methods used in hospitals.
Heating to 134 degrees Celsius (273 degrees Fahrenheit) does not
reduce their infectivity.8
Similar Diseases in Other Species
Transmissible encephalopathies
have long been documented in animals in the United States, indicating
the need to protect human populations. Scrapie, the encephalopathy
analogous to BSE occurring in sheep and which may have been the
origin of BSE, was first reported in the United States in 1947,
and infected sheep flocks have been identified in virtually all
parts of the United States where sheep are raised.9,
10 Similar diseases have been found in other species,
including chronic wasting disease in deer and elk, and transmissible
mink encephalopathy.8 While scrapie is
not known to cause human disease, passage of the prions that cause
scrapie through other animals may potentially alter their infectivity
and disease presentation.
Indirect evidence from
mink on fur farms who were routinely fed cattle-derived remains
suggests that BSE may have been present as early as 1985 in at least
some U.S. cattle. In at least five separate outbreaks, mink fed
in this way have developed a disease called transmissible mink encephalopathy
(TME) which is remarkably like BSE.4, 11
After a 1985 TME outbreak in Stetsonville, Wisconsin, experimenters
injected brain tissue from diseased mink into Holstein cattle, finding
that the cattle developed spongiform encephalopathy. They then fed
remains of these cattle to healthy mink, who soon developed TME.12
Reviewing evidence that the mink disease came from cattle-based
feeds, University of Wisconsin researchers concluded, “If
this is true, there must exist an unrecognized bovine spongiform
encephalopathy (BSE)-like infection in American cattle.” 12
In other words, U.S. cattle have been sporadically infected with
BSE, which has shown its pathological effects when passed on to
other species.
The Failure of U.S. Government Policies
The fact is that USDA
officials have not been seriously looking for BSE cases. Data from
the National Veterinary Sciences Laboratories BSE Surveillance program
from 1990 to 2000 show that, of approximately 900 million cattle
slaughtered, only 11,954 brains (approximately 1 in 75,000) were
examined for BSE. In fiscal year 2002, the USDA tested only slightly
more—19,990—cattle for BSE.13
Further, brain examinations have generally been prompted by the
presence of neurological symptoms. However, the symptoms of BSE
do not commonly manifest in cattle until about five years of age,
which is after the usual age of slaughter. For example, most U.S.
dairy cows are slaughtered before four years of age, when even a
prion-infected cow is likely to appear healthy. In the UK, 70 percent
of dairy cows remain alive past this point, making identification
of infected animals much easier. 3 Despite
all this, the first official U.S. case was recently identified in
a cow raised in Washington State.
The USDA has been slow to take steps against the potential spread
of encephalopathies from one animal to another, or from animals
to humans. Since 1989, the U.S. government has banned the import
of live ruminants (cattle, sheep, goats) and most ruminant products
from countries where BSE has been reported, and, in December 2000,
the USDA prohibited imports of animal-derived livestock feeds from
Europe, regardless of species of origin, after determining that
feed derived from non-ruminant species was potentially cross-contaminated
with BSE. However, given that BSE is already present in the United
States, appropriate steps are needed to protect against its spread.
The measures instituted so far by the U.S. government are grossly
inadequate, as evidenced by the following examples:
Monitoring for human illness
is even more haphazard. Transmissible encephalopathies are not yet
reportable diseases for the Centers for Disease Control and Prevention.
Individuals showing signs of dementia due to such a condition may
be misdiagnosed as suffering from Alzheimer's disease or stroke,
and most dying with neurological illnesses are never autopsied,
so their brains are never examined.
There is simply no way
of knowing whether vCJD has begun in the United States or not. Death
certificates from 1979 to 1998 show that 4,751 people were identified
with CJD in the United States. While the presumption is that they
had the “classical” form of the disease, rather than
the new variant form which is believed to come from animal tissues,
this remains uncertain. While most victims were older (a sign of
classical CJD), a small number were surprisingly young.2
The reported cases are probably underestimates due to the problems
of misdiagnosis and underreporting.
On a more optimistic note,
restrictions on blood products are becoming more stringent, which
is appropriate given that they may also be vectors of disease.14
Currently, people who have spent a cumulative total of three months
or more in the United Kingdom since 1980 or a total of six months
or more in any European country or combination of countries are
not permitted to donate blood in the United States. Nonetheless,
it is clear that diseases closely related to vCJD exist in the United
States, both in animals and humans, that these diseases should be
considered highly infectious, that monitoring programs are too spotty
to track the extent of these diseases, and that current preventive
steps are far too lax.
Recommendations
- The following are PCRM’s recommendations to the government
for protecting the public against vCJD:
- Ban the use of animal-derived livestock feeds for any species,
given the likelihood that animal byproducts will, in turn, be
recycled to ruminants (that is, cows, sheep, and goats).
- Ban the slaughter of downed animals, animals too sick to stand,
for human food. The Washington state cow that tested positive
for mad cow disease in December 2003 was a downed animal.
- Prohibit animal byproducts in all medications, supplements,
or cosmetics.
- Label all foods containing animal byproducts (such as gelatin
or “natural flavorings”), indicating both the presence
of animal byproducts and the species of origin.
- Provide warning labels on all foods that carry a risk of vCJD,
using standards similar to those for tobacco and alcohol products.
- Institute comprehensive monitoring programs to check for diseased
animals and humans in the United States. Monitoring programs for
BSE and other encephalopathies in animals should include but not
be limited to testing all suspect animals (rather than a fraction
of them) and holding back the carcasses of tested animals from
the food supply until the test results are known. For humans,
monitoring programs should be implemented that require all states
to report CJD cases and dementia of unknown cause (especially
in young individuals) to the Centers for Disease Control so that
any cases where vCJD is suspected can be confirmed or dismissed
by autopsy.
It should be recognized that the consumption of livestock products
is clearly linked to a much higher risk of serious and sometimes
fatal diseases, apart from the risk of transmissible encephalopathies.
These diseases include coronary artery disease, colon and possibly
other forms of cancer, diabetes, hypertension, obesity, and infection
with salmonella, campylobacter, and E.coli O157:H7, among others.
Making meat “safe” is not a realistic or attainable
goal. Ironically, while the feeding of animal remains to other animals
is now acknowledged as a dangerous practice that is restricted in
some countries, the feeding of animal remains to humans is encouraged
by government programs and massive industry efforts.
References
1. www.cfsan.fda.gov/~comm/bsefaq.html
2. Gibbons RV, Holman RC, Belay ED, Schonberger LB. Creutzfeldt-Jakob
disease in the United States: 1979-1998. JAMA. 2000 Nov 8;284(18):2322-3.
3. Walker KD, Hueston WD, Hurd HS, Wilesmith JW. Comparison of bovine
spongiform encephalopathy risk factors in the United States and
Great Britain. JAVMA 1991;199:1554-61.
4. Marsh RF. Bovine spongiform encephalopathy: a new disease of
cattle? Arch Virol 1993;7(Suppl):255-9.
5. Prusiner SB. The prion diseases. Scientific American, Jan 1995,
pp. 48-57.
6. Bleem AM, Crom RL, Francy B, Hueston WD, Kopral C, Walker K.
Risk factors and surveillance for bovine spongiform encephalopathy
in the United States. JAVMA 1994;204:644-51.
7. Collee JG. A dreadful challenge. Lancet 1996;347:917-8.
8. Steelman VM. Creutzfeld-Jakob disease: recommendations for infection
control. Am J Infect Control 1994;22:312-8.
9. Bleem AM, Crom RL, Francy B, Hueston WD, Kopral C, Walker K.
Risk factors and surveillance for bovine spongiform encephalopathy
in the United States. JAVMA 1994;204:644-51.
10. Miller LD, Davis AJ, Jenny AL. Surveillance for lesions of bovine
spongiform encephalopathy in US cattle. J Vet Diagn Invest 1992;4:338-9.
11. Robinson MM, Hadlow WJ, Huff TP, et al. Experimental infection
of mink with bovine spongiform encephalopathy. J Gen Virol 1994;75:2151-5.
12. Marsh RF, Bessen RA. Epidemiologic and experimental studies
on transmissible mink encephalopathy. Dev Biol Stand 1993;80:111-8.
13. www.usda.gov/news/releases/2003/05/bg0166.htm
14. Foster PR. Prions and blood products. Ann Med 2000;32:501-13.
Media
Center | Health | Research
| About PCRM | Catalog
| Join Us | Search
| Site Index | Home
The site does
not provide medical or legal advice. This Web site is for information purposes
only.
Full Disclaimer | Privacy Policy
|